Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Sci Rep ; 4: 4432, 2014 Mar 21.
Article in English | MEDLINE | ID: mdl-24651255

ABSTRACT

Aberrant DNA methylation is a hallmark of cancer and is an important potential biomarker. Particularly, combined analysis of a panel of hypermethylated genes shows the most promising clinical performance. Herein, we developed, optimized and standardized a multiplex MethyLight assay to simultaneously detect hypermethylation of APC, HOXD3 and TGFB2 in DNA extracted from prostate cancer (PCa) cell lines, archival tissue specimens, and urine samples. We established that the assay is capable of discriminating between fully methylated and unmethylated alleles with 100% specificity and demonstrated the assay as highly accurate and reproducible as the singleplex approach. For proof of principle, we analyzed the methylation status of these genes in tissue and urine samples of PCa patients as well as PCa-free controls. These data show that the multiplex MethyLight assay offers a significant advantage when working with limited quantities of DNA and has potential applications in research and clinical settings.


Subject(s)
Adenomatous Polyposis Coli Protein/genetics , DNA Methylation , Homeodomain Proteins/genetics , Multiplex Polymerase Chain Reaction/methods , Prostatic Neoplasms/genetics , Transforming Growth Factor beta2/genetics , Adenomatous Polyposis Coli Protein/urine , Cell Line, Tumor , CpG Islands , DNA Primers/chemistry , DNA, Neoplasm , Homeodomain Proteins/urine , Humans , Male , Promoter Regions, Genetic , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/urine , Reproducibility of Results , Sensitivity and Specificity , Transcription Factors , Transforming Growth Factor beta2/urine
2.
Am J Physiol Renal Physiol ; 292(6): F1681-90, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17311907

ABSTRACT

Puberty unmasks or accelerates progressive kidney diseases, including diabetes mellitus (DM), perhaps through effects of sex steroids. To test the hypothesis that rising androgen levels at puberty permit diabetic kidney damage, we studied four groups of male rats with and without streptozocin-induced DM: adult onset (A), adult onset after castration (AC), juvenile onset (J), and juvenile onset with testosterone treatment (JT). Profibrotic markers were measured after 6 wk with blood glucose levels 300-450 mg/dl. JT permitted increased expression of mRNA for two isoforms of transforming growth factor-beta and connective tissue growth factor compared with J animals with DM; prior castration did not provide protection in adult-onset DM. JT also permitted greater tubular staining for alpha-smooth muscle actin and fibroblast-specific protein, two markers of cell damage and potential epithelial mesenchymal transition. Once again, castration was not protective for these effects of DM in the AC group. These data indicate that puberty permits detrimental effects in the tubulointerstitium in the diabetic kidney, an effect mimicked by testosterone treatment of juvenile animals and partially blunted by castration of adults, but damage does not correlate with testosterone levels, suggesting a less direct mechanism.


Subject(s)
Diabetes Mellitus, Experimental/pathology , Diabetic Nephropathies/pathology , Kidney Tubules/pathology , Testosterone/toxicity , Animals , Connective Tissue Growth Factor , Immediate-Early Proteins/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Kidney Tubules, Distal/pathology , Kidney Tubules, Proximal/pathology , Male , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Sexual Maturation , Tissue Fixation , Transforming Growth Factor beta1/biosynthesis , Transforming Growth Factor beta1/blood , Transforming Growth Factor beta1/urine , Transforming Growth Factor beta2/biosynthesis , Transforming Growth Factor beta2/blood , Transforming Growth Factor beta2/urine , Transforming Growth Factor beta3/biosynthesis , Transforming Growth Factor beta3/blood , Transforming Growth Factor beta3/urine
SELECTION OF CITATIONS
SEARCH DETAIL